The Kitty Kidney: What's New with CKD?
Chronic kidney disease (CKD) is a common problem in companion animal practice, and it is estimated that >10% of cats over 10 years of age are affected. In recent years, new guidelines have been developed to facilitate effective patient management, but there is still some confusion about optimal care for these patients. In addition, new diagnostic and therapeutic options regularly appear and it can be challenging to evaluate their potential benefits and limitations.
In this lecture, we will review new options for identifying and managing CKD in cats,including measurement of symmetric dimethylarginine (SDMA), indications for a urine culture, the angiotensin II receptor blocking agents (ARBs), and subcutaneous ureteral bypass devices (SUBs). Appetite stimulants and decision-making on protein restriction will also be discussed.
- At the end of this lecture, attendees will be able to:
- - Explain the clinical utility/ limitations of SDMA
- - Identify reasons to prescribe telmisartan
- - Discuss the indications and complexities of the SUB device